Skip to main content

Day: March 18, 2022

High Arctic Announces Amendment to March 11, 2022 Press Release

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, March 18, 2022 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) “High Arctic” or the “Corporation” announces a correction to specific information contained in the press release of March 11, 2022. The TSX has set the ex-dividend date for the $0.005 per share dividend payable on May 12, 2022 as Thursday, April 28, 2022. The Company previously announced the ex-dividend date as Friday, April 29, 2022. About High Arctic High Arctic’s principal focus is to provide drilling and specialized well completion services, equipment rentals and other services to the oil and gas industry. High Arctic is a market leader...

Continue reading

Chicken Soup for the Soul Entertainment Announces Timing of Regular Monthly Dividend for April for Series A Cumulative Redeemable Perpetual Preferred Stock

COS COB, Conn., March 18, 2022 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE, CSSEP, CSSEN), one of the largest operators of streaming advertising-supported video-on-demand (“AVOD”) networks, today announced the timing for the payment of its declared regular monthly dividend of $0.2031 per share of its 9.75% Series A Cumulative Redeemable Perpetual Preferred Stock for April 2022. The dividend will be payable on April 15, 2022 to holders of record as of March 31, 2022. The dividend will be paid in cash. ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENT Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) (the “Company”) operates streaming video-on-demand networks (VOD). The Company owns Crackle Plus, which owns and operates a variety of ad-supported and subscription-based VOD networks including...

Continue reading

Nymox Announces $5 Million Registered Direct Offering

IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive agreements with institutional and accredited investors for the purchase and sale of 3,030,304 common shares at a purchase price of $1.65 per share in a registered direct offering for gross proceeds of approximately $5 million before deducting placement agent fees and expenses. The Company has also agreed to issue to the investors, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 3,030,304 common shares. The warrants are exercisable immediately at an exercise price of $2.00 per share and will expire five (5) years from the date of an effective registration statement covering the shares underlying the warrants. The closing of the offering is expected...

Continue reading

Palisade Bio (Nasdaq: PALI) Reports Year End 2021 Financial Results and Corporate Update

CARLSBAD, Calif., March 18, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical stage biopharmaceutical company advancing oral therapies to aid patients suffering with acute and chronic gastrointestinal (GI) complications, today provides a business update and reports its financial results for the year ended December 31, 2021. Highlights and Recent Events “This past year was a transformative year for Palisade Bio. In April, we completed the merger of Seneca and Leading BioSciences and concurrent $22 million in financing. This was important because it provided the company with financial resources and access to capital to advance our clinical programs, add talent, and mature our operations in advance of late-stage studies. This milestone was followed just a few months later with we believe...

Continue reading

MEGlobal and Capital Power Announce a 10-year Renewable Energy Agreement

MEGlobal Canada moving to 100% Renewable Energy for its Alberta sites EDMONTON, Alberta, March 18, 2022 (GLOBE NEWSWIRE) — MEGlobal Canada ULC (MEGlobal) has entered into a 10-year agreement with Capital Power Corporation (TSX: CPX) to purchase a significant share of renewable energy (126 megawatts) from Capital Power’s Whitla Wind1 facility. The renewable energy is expected to meet the power needs at MEGlobal’s Canadian manufacturing facilities beginning April 1, 2022. MEGlobal is a subsidiary of EQUATE Petrochemical Company K.S.C.C. (EQUATE) and part of the EQUATE Group. MEGlobal has three operational sites in Alberta, located in Fort Saskatchewan and Lacombe County. These facilities produce ethylene glycol that is used to make essential products such as clothing, coolants and construction materials. “Purchasing energy from renewable...

Continue reading

MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

AgenT-797 (Allo-iNKTs) +/- anti-PD-1 clinical trial underway in solid tumor cancers Benefit in severe COVID-19 ARDS shows 75% survival rate in patients treated with Allo-iNKTs AgenT-797 treatment with no lymphodepletion shows no cytokine release syndrome or neurotoxicity 2021 annualized cash burn is ~ $13MNEW YORK, March 18, 2022 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, reported financial results for the fourth quarter and full year 2021. “We have advanced our allo-iNKT program with multiple clinical programs in solid tumor cancers, multiple myeloma, and a variant agnostic therapy...

Continue reading

Align Technology Launches New Invisalign System Innovations for Orthodontic and Restorative Dental Treatment Planning with Integration of CBCT into ClinCheck Treatment Planning Software

Digitally integrating Cone Beam Computed Tomography (CBCT) scan and intraoral scan data into ClinCheck treatment plans enables doctors to confidently expand diagnosis and treat a broader range of cases with Invisalign clear aligners TEMPE, Ariz., March 18, 2022 (GLOBE NEWSWIRE) — Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry today announced the new Cone Beam Computed Tomography (CBCT) integration feature for ClinCheck digital treatment planning software, a user-friendly tool that combines roots, bone, and crowns into a single three-dimensional model that enables doctors to visualize a patient’s roots as part...

Continue reading

HUMBL Announces “Project: Search 3”

Santiago, Chile, March 18, 2022 (GLOBE NEWSWIRE) — Speaking at the launch of the Latin America Blockchain Accelerator (LABS) in Santiago, Chile, the CEO of HUMBL, Inc. (OTCQB:HMBL), Brian Foote, announced that it has launched “Project: Search 3.” The initiative will result in the production of “Search 3,” one of the world’s first modular, blockchain-based Web 3 search engines. The company announced that it is already well underway on the building of the technology, which is expected to ship to the global markets sometime in the first half of calendar year 2022. “The challenge of building a decentralized Web 3 that is still easily discoverable, well organized and verifiable on blockchain for users, is both groundbreaking and exciting,” said HUMBL CEO, Brian Foote. “We view Search 3 as a simple discovery layer that provides verifiable...

Continue reading

CISA “Shields Up” Warning in Light of Ukraine Conflict Means Businesses Must Act Now to Bolster Cybersecurity Posture, Says Cerberus Sentinel CEO

David Jemmett shares insights, counsel to help organizations globally to protect themselves from digital cybersecurity disaster SCOTTSDALE, Ariz., March 18, 2022 (GLOBE NEWSWIRE) — via InvestorWire — The Russian aggression in Ukraine is unlike any global conflict most people have seen in their lifetimes, creating both humanitarian crises as well as fomenting cybersecurity insurrection that few organizations are prepared to weather, said David Jemmett, CEO, Cerberus Cyber Sentinel Corporation (Nasdaq: CISO), a global Managed Compliance and Cybersecurity Provider (MCCP) based in Scottsdale, Ariz. CISA (Cybersecurity and Infrastructure Security Agency), the U.S. federal government’s key cybersecurity communications arm, recommended in a recent “Shields Up” posting that, due to the ongoing conflict in Ukraine, “all...

Continue reading

Dentsply Sirona to Participate in the Piper Sandler Virtual Dental Day

CHARLOTTE, N.C., March 18, 2022 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will participate in the Piper Sandler Virtual Dental Day. Don Casey, Chief Executive Officer, is scheduled to participate in a fireside chat discussion on Tuesday, March 29, 2022 at 1:00 pm ET. A live webcast will be available on the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. A replay of the webcast will be available for 30 days following the discussion. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 135-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.